Emcure Pharmaceuticals Limited
NSE: EMCUREINE168P01015·HealthcareSmallcap 250·www.emcure.com ↗·Mcap ₹37,585 Cr·Listed 2024
₹1,950.60▼ ₹1.50  (−0.08%)
52W: ₹1,260 – ₹2,101 · Vol: 32.4K shares · Close 25 Sept
Set Alert
Overlay:
daily candles · adjustedloading full history…Charts by TradingView
Ask the chart: “Has this stock recovered from similar drawdowns before?”
Annual report FY26 — 11.80 MB · Shareholding pattern — Jun 2026 · All filings
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon

Latest filings

NSE announcements · newest first
Investor Presentation
Presentation25 Sept 2026 PDF
Change in composition of the Board of the Company.
General update23 Sept 2026 PDF
Copy Srutinizers report of Annual General Meeting held on September 21, 2026. Further, the company has informed the Exchange regarding voting results.
Voting result23 Sept 2026 PDF
Proceedings of Annual General Meeting held on September 21, 2026
AGM / EGM21 Sept 2026 PDF
All filings →
P/E (TTM)
36.3×
EPS ₹53.75
P / Book
7.47×
BVPS ₹261
ROE
20.0%
FY26, avg equity
Net margin
10.2%
FY26
Revenue YoY
+22.8%
Q1 FY27
Net profit YoY
+36.2%
Q1 FY27
Debt / equity
0.24×
₹1,204 Cr debt
Div. yield
0.18%
₹3.60 in 12 months
From NSE filings (consolidated) and the last close.
Shareholding Pattern Jun 2026
Promoters
77.8%▼ 0.04
FIIs
4.9%▲ 1.53
DIIs
8.5%▲ 2.36
Retail
6.5%▼ 0.01
Others
2.4%▼ 3.84
Promoter pledge: none reported
Peer Comparison
CompanyP/EP/BROEMargin
GLAND₹48,064 Cr42.6×4.64×10.5%16.0%
AJANTPHARM₹44,472 Cr39.2×9.82×25.4%19.4%
EMCURE₹36,981 Cr36.3×7.47×20.0%10.2%
WOCKPHARMA₹36,703 Cr88.7×7.43×4.3%5.9%
SAILIFE₹33,720 Cr93.2×13.58×15.1%15.9%
NEULANDLAB₹28,239 Cr56.7×15.07×21.4%18.0%
Pharmaceuticals: the companies closest in market value, of the 108 in that basic industry whose filings we hold. Computed from each company's NSE filings (up to Q1 FY27) and the last close; hover a column for its definition.
Forensic Flags
No check is outside its threshold.
13 checks within their thresholds
Operating cash flow was 1.09× net profit
Cumulative over FY25–FY26 (2 years).
Free cash flow was negative in 0 of the last 2 years
Operating cash flow less capital expenditure, as filed.
Receivables grew 28% against revenue growth of 17%
FY26: debtor days moved from 93 to 102.
Inventory grew 24% against revenue growth of 17%
FY26: inventory days moved from 89 to 95.
Debt to equity is 0.24×
As at 2026-03-31.
Profit before interest and tax covers finance costs 10.0×
FY26.
Other income is 1% of profit before tax
FY26.
Exceptional items above 5% of pre-tax profit in 0 of the last 2 years
FY25–FY26.
Effective tax rate averaged 27%
Tax over pre-tax profit, last 2 years. The base corporate rate is about 25%.
Promoter holding is 77.83%, -0.08 points over a year
2026-06-30 against 2025-06-30.
No promoter shares are pledged
Shareholding pattern as at 2026-06-30.
No auditor change or resignation filings in three years
From NSE announcements on record.
Results were filed late in 0 of the last 8 quarters
Slowest filing came 52 days after the period end.
Computed from NSE filings (consolidated). Colours follow fixed thresholds, shown on hover. These are facts about the filings, not advice. 1 check not run for lack of data.
Formula Scores
Piotroski F-score: 7 of 9 · FY to 2026-03-31
one point for each of nine tests on profitability, leverage and liquidity, and operating efficiency, comparing the year with the one before
  • ✓ Return on assets positive: 11.43 — profit after tax over the year's opening total assets, %
  • ✓ Operating cash flow positive: 943.5 — ₹ crore
  • ✓ Cash flow above profit (accruals): 2.3 — operating cash flow less profit after tax, ₹ crore
  • ✓ Return on assets improved: 2.84 — change in ROA, percentage points
  • ✗ Long-term borrowings to assets fell: 0.32 — change in long-term borrowings over total assets, percentage points
  • ✗ Current ratio improved: -0.28 — change in current assets over current liabilities
  • ✓ No new shares issued: 0.06 — change in share capital, %
  • ✓ Gross margin improved: 0.95 — revenue less material cost over revenue, change in percentage points
  • ✓ Asset turnover improved: 0.159 — revenue over the year's opening total assets, change
Inputs: profit after tax ₹941 Cr (2026-03-31) · profit after tax ₹707 Cr (2025-03-31) · total assets ₹9,612 Cr (2026-03-31) · total assets ₹8,233 Cr (2025-03-31)
The paper's bands: 8–9: the paper's high group; 0–2: the paper's low group
Source: Joseph Piotroski, "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers", Journal of Accounting Research, 2000
Altman Z-score: 7.23 · FY to 2026-03-31
Z = 1.2 × working capital / total assets + 1.4 × retained earnings / total assets + 3.3 × EBIT / total assets + 0.6 × market value of equity / total liabilities + 1.0 × sales / total assets
  • working capital / total assets: 0.187 × 1.2
  • retained earnings / total assets: 0.495 × 1.4 — reserves and surplus as retained earnings
  • EBIT / total assets: 0.149 × 3.3 — profit before tax plus finance cost
  • market value of equity / total liabilities: 8.107 × 0.6 — market capitalisation over total assets less equity
  • sales / total assets: 0.957 × 1
Inputs: total assets ₹9,612 Cr (2026-03-31) · current assets ₹5,709 Cr (2026-03-31) · current liabilities ₹3,912 Cr (2026-03-31) · reserves ₹4,760 Cr (2026-03-31) · total equity ₹4,977 Cr (2026-03-31) · profit before tax ₹1,287 Cr (2026-03-31) · finance cost ₹144 Cr (2026-03-31) · revenue ₹9,204 Cr (2026-03-31) · market capitalisation (today) ₹37,585 Cr
The paper's bands: above 2.99: the paper's safe zone; 1.81–2.99: the grey zone; below 1.81: the distress zone
the 1968 form, fitted on manufacturers; reserves stand in for retained earnings, and profit before tax plus finance cost for EBIT
Source: Edward Altman, "Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy", Journal of Finance, 1968
Graham number: 535.26 ₹ per share · FY to 2026-03-31
√(22.5 × earnings per share × book value per share): the price at which P/E × P/B = 22.5 (a P/E of 15 at a P/B of 1.5)
  • earnings per share: 48.77
  • book value per share: 261.09 — owners' equity over shares (paid-up capital / face value)
Inputs: earnings per share 48.77 (2026-03-31) · owners' equity ₹4,950 Cr (2026-03-31) · paid-up capital ₹190 Cr (2026-03-31) · face value 10 (2026-03-31)
a number the book uses as a ceiling for a defensive investor's purchase price; it is arithmetic on two reported figures, not a valuation
Source: Benjamin Graham, The Intelligent Investor (1949; the 22.5 in the 1973 edition's criteria for the defensive investor)
Sloan accrual ratio: -0.03 % of assets · FY to 2026-03-31
(profit after tax − operating cash flow) / average total assets
Inputs: profit after tax ₹941 Cr (2026-03-31) · operating cash flow ₹944 Cr (2026-03-31) · total assets ₹9,612 Cr (2026-03-31) · total assets ₹8,233 Cr (2025-03-31)
how much of the year's profit was not cash; the paper sorts companies by this and reports the top decile's later returns
Source: Richard Sloan, "Do Stock Prices Fully Reflect Information in Accruals and Cash Flows about Future Earnings?", The Accounting Review, 1996
Each score is its published formula applied to the company's own filings (consolidated); open one for the tests, the inputs and the paper. Arithmetic on the filings, not a view on the stock.